Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-19-058172

President and CEO sold 43,485 shares at an average $18.02 ($783,574)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2019-11-22 Sale −1,300 $18.00 $23,400 2,492,757 I
Watts Ryan J. President and CEO 2019-11-25 Sale −42,185 $18.02 $760,174 2,450,572 I
Open-market sales · 43,485 sh · avg $18.02 · $783,574
Loading xslF345X03/doc4.xml…